Interactions between Gepotidacin and Escherichia coli Gyrase and Topoisomerase IV: Genetic and Biochemical Evidence for Well-Balanced Dual-Targeting
ACS Infectious Diseases · 2024
DOI: 10.1021/acsinfecdis.3c00346 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Infectious Diseases, 2024. Verfasst von Alexandria A Oviatt und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, United States. Hauptthemen laut MEDLINE: Acenaphthenes, DNA Topoisomerase IV, Escherichia coli, Heterocyclic Compounds, 3-Ring. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NCI NIH HHS, BLRD VA.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, United States.
- Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, United States.
- Infectious Diseases Research Unit, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States.
- Laboratory of Single Molecule Biophysics, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20982, United States.
- Department of Medicine (Hematology/Oncology), Vanderbilt University School of Medicine, Nashville, Tennessee 37232, United States.
- VA Tennessee Valley Healthcare System, Nashville, Tennessee 37212, United States.
ORCID-Profile: Alexandria A Oviatt, Elizabeth G Gibson, Neil Osheroff
Förderung
- NIAID NIH HHS
- NCI NIH HHS
- BLRD VA
- Intramural NIH HHS
- NIGMS NIH HHS
- National Cancer Institute
- U.S. Department of Veterans Affairs
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Oviatt, A. A., Gibson, E. G., Huang, J., Mattern, K., Neuman, K. C., Chan, P. F., & Osheroff, N. (2024). Interactions between Gepotidacin and Escherichia coli Gyrase and Topoisomerase IV: Genetic and Biochemical Evidence for Well-Balanced Dual-Targeting. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.3c00346
Vancouver
Oviatt AA, Gibson EG, Huang J, Mattern K, Neuman KC, Chan PF, et al. Interactions between Gepotidacin and Escherichia coli Gyrase and Topoisomerase IV: Genetic and Biochemical Evidence for Well-Balanced Dual-Targeting. ACS Infectious Diseases. 2024. doi:10.1021/acsinfecdis.3c00346
BibTeX
@article{Oviatt2024,
author = {Oviatt, Alexandria A and Gibson, Elizabeth G and Huang, Jianzhong and Mattern, Karen and Neuman, Keir C and Chan, Pan F and Osheroff, Neil},
title = {Interactions between Gepotidacin and Escherichia coli Gyrase and Topoisomerase IV: Genetic and Biochemical Evidence for Well-Balanced Dual-Targeting},
journal = {ACS Infectious Diseases},
year = {2024},
doi = {10.1021/acsinfecdis.3c00346}
}
EUVIMED